Diminished Ovarian Reserve: What the Diagnosis Misses

You are told you have diminished ovarian reserve. And the conversation immediately shifts to urgency.

Protocols get discussed. Timelines compress. Donor eggs get mentioned sooner than expected. The urgency is real but urgency is not the same as completeness. And somewhere in that conversation, the question that matters most never gets asked.

Not which protocol to use. Why the reserve looks the way it does. What has been driving it. Whether anything in that picture has ever actually been evaluated.

Diminished ovarian reserve (DOR) describes capacity. It does not explain outcome.

DOR is not a diagnosis. It is a classification based on how the ovaries are responding at a single point in time. Two women can have identical DOR markers and completely different fertility pictures depending on what is driving it underneath. That distinction is where everything changes. And it is the one that almost never gets made.

"Something inside me knew my body wasn't broken. It was just waiting for the right support."

What DOR Actually Measures and What It Does Not

DOR is defined by three markers: AMH below 1.0 ng/mL, antral follicle count fewer than five to seven follicles on day 2 or 3 of the cycle, and day 3 FSH above 10 mIU/mL. Together they indicate that the pool of follicles currently being recruited is reduced relative to age expectations.

That is the complete picture the classification provides. It says nothing about egg quality, the biological environment those follicles are developing inside, or whether the systems driving follicle recruitment have ever been evaluated.

DOR is not the same as primary ovarian insufficiency (POI).

POI involves cessation of menstrual function before age 40 with elevated FSH, low estrogen, and absent or highly irregular cycles. DOR describes reduced reserve while cycles are still present. These are different biological situations requiring different evaluations.

The POSEIDON criteria classifies poor ovarian response by age, reserve markers, and stimulation history. It shapes protocol design. It does not address what is driving the reserve picture in the first place.

Symptoms Worth Paying Attention To

Most women find out they have DOR from a test, not from symptoms. But some notice a shortening cycle moving from 28 days to 24 or 25 without explanation. Lighter periods. Changes in premenstrual patterns. These are easy to normalize. They are the body signaling that follicle recruitment is shifting.

DOR at Any Age

In a younger woman, DOR signals something biological is driving accelerated decline not an inevitable outcome of age. In a woman over 40, the clinical conversation moves fastest toward protocol. What gets missed at every age is the same: what is driving the reserve picture, and has anyone looked.

Over 40 with DOR and unaddressed Hashimoto's, elevated inflammation, depleted nutrients, and a progesterone pattern never properly measured is a completely different biological situation from the same numbers in a woman whose full picture has been evaluated. The diagnosis looks identical. The environment it is sitting inside of is not.

Pregnancy after 40 with low AMH and high FSH

DOR and Endometriosis

Endometriomas directly affect ovarian tissue and can accelerate reserve decline. The chronic inflammatory state associated with endometriosis affects the ovarian environment independently of any cysts. When DOR and endometriosis appear together, the inflammatory picture is almost never evaluated as a connected system.

DOR and Recurrent Pregnancy Loss

The inflammatory and autoimmune patterns that accompany DOR are independent contributors to pregnancy loss. When recurrent loss and DOR appear together, the evaluation needs to go beyond reserve markers to thyroid antibodies, ANA, hsCRP, homocysteine, and progesterone at the right cycle point. These patterns explain why she can get pregnant and cannot stay pregnant. They are almost always sitting in the background untouched.

What Causes Diminished Ovarian Reserve?

Not all DOR has the same origin. Understanding which category is driving the picture shapes what the evaluation needs to look at.

• Age related decline the most common category. Reserve naturally decreases over time, with the rate of decline varying significantly between individuals.
• Iatrogenic caused by medical intervention. Ovarian surgery, chemotherapy, radiation, or endometrioma removal can reduce reserve directly. The surgical history matters.
• Autoimmune related immune activation, particularly thyroid autoimmunity, is associated with accelerated reserve decline and is consistently under evaluated in standard workups.
• Metabolic and inflammatory driven chronic inflammation, insulin resistance, nutritional depletion, and environmental toxin burden can drive reserve decline independently of age.
• Idiopathic no identifiable cause. In practice, most idiopathic DOR falls into patterns that were never fully investigated. The absence of a conventional explanation is not the same as the absence of a cause.

If this has never been categorized properly, the reserve number is being interpreted without context.

Why Most DOR Plans Do Not Change the Outcome

Most women at this stage have already done a great deal. Diet changes, supplements, multiple cycles, protocol adjustments. The same result repeats. The reason is almost always one of three things.

Protocol changes are not the same as environment changes.

Higher stimulation doses increased eggs retrieved across 38 randomized controlled trials. They did not improve clinical pregnancy rates. The eggs were developing in the same biological environment as the previous cycle. Changing the dose does not change that environment.

Conforti A et al. Therapeutic management in women with DOR: RCT meta analysis. Fertil Steril. 2024.

Supplements are not the same as a targeted intervention.

CoQ10, vitamin D, methylfolate real evidence exists for this population. But without absorption testing, supplementation is guesswork. If the gut has never been evaluated, the supplements are not reaching target tissues.

Testing is not the same as interpretation.

The issue is rarely that tests were not run. It is whether results were read as a connected biological pattern across systems or whether each marker was evaluated in isolation against a standard lab range. Those are different conversations with different outcomes.

This does not replace medical care or IVF. It changes how the data is interpreted before the next step.

If you have already done multiple cycles or are being told to move quickly, this is usually the point where a deeper review changes the direction.

How to prepare for a successful egg retrieval with low AMH and DOR

What a Complete DOR Evaluation Actually Includes

A standard workup measures the reserve markers. A complete evaluation looks at the systems that shape them. Here is what is almost always missing.

• Full thyroid panel with antibodies Free T3, Free T4, TSH, TPO antibodies, thyroglobulin antibodies, and Reverse T3
• Inflammation markers hsCRP below 1 mg/L functional target, homocysteine at 6.0 to 7.2 µmol/L functional range, ANA
• Iron status full iron panel including ferritin at the functional threshold of 80 to 100 ng/mL
• Hormonal picture with correct timing progesterone measured seven days post ovulation, DHEA S, full cortisol curve via DUTCH testing
• Gut assessment functional stool testing for dysbiosis, infections, absorption markers, food sensitivity panel
• Nutrient status vitamin D at 60 to 80 ng/mL functional target, B12 at 800 to 900 pg/mL, magnesium RBC, zinc, selenium
• Environmental load Hair Tissue Mineral Analysis for heavy metals and mineral depletion together
• Male testing where a partner is involved sperm DNA fragmentation and seminal microbiome

These are standard functional fertility markers that are almost never included in a conventional DOR workup. When evaluated together as a system, the picture that emerges is almost always different from what the reserve markers alone suggest.

Your labs are normal but are they: 20 overlooked blood markers 

The Patterns That Shape Ovarian Reserve

This is the evaluation that almost never happens in a standard DOR workup. Each pattern has a documented connection to reserve decline, egg quality, and fertility outcomes.

Hormonal Signaling Thyroid and Adrenals

These two systems drive the HPO axis and are almost always evaluated separately when they need to be read together.

Thyroid: The pattern we see regularly is Hashimoto's managed on medication, assumed handled, antibodies never rechecked. TPO antibodies detected in follicular fluid create an inflammatory environment around the developing egg regardless of TSH. Non celiac gluten sensitivity driving autoimmune thyroid activation is a pattern worth evaluating in this population. If thyroid function has never been assessed beyond TSH, the reserve number is being interpreted without that context.

Adrenals: Chronic stress keeps cortisol elevated, suppressing FSH and LH signaling and depleting DHEA. The DUTCH test maps the cortisol curve across the full day a flat curve with depleted DHEAS is a pattern we see regularly that never shows up on a single cortisol blood draw.

Hashimoto's Thyroiditis and Female Fertility. PMC. 2025.

Is your thyroid impacting egg health and DOR

Stress, low AMH and fertility: how the hyper-achiever pattern affects ovarian reserve 

Inflammatory and Immune Load

Chronic inflammation is one of the most consistently overlooked drivers of reserve decline. hsCRP between 1 and 3 mg/L is associated with a 67% increased risk of pregnancy loss standard labs consider it unremarkable.

• Homocysteine elevated above 7.2 µmol/L directly correlated with poorer embryo quality in women with DOR, driven by MTHFR variants and B vitamin deficiency. Not folic acid. Methylfolate.
• ANA positivity present in approximately 20% of infertile women, associated with significantly lower IVF pregnancy rates
• If none of these have been measured, the immune picture behind the reserve decline has never been seen

Wang H et al. Homocysteine and embryo quality in DOR. Front Reprod Health. 2022.

Ticconi C et al. Antinuclear antibodies in reproductive age women. J Reprod Immunol. 2023.

Stop ignoring hsCRP and the role of inflammation in DOR 

Metabolic and Blood Sugar Patterns

Subclinical insulin resistance sitting inside normal lab ranges with no obvious symptoms is enough to suppress ovarian steroidogenesis and impair how follicles develop. The pattern in the history: afternoon energy crashes, waking at 3am, feeling significantly better after eating.

Oat milk spikes blood sugar in ways many women have not connected to their ovarian picture. It is positioned as a healthy swap. For this population it is not a neutral choice.

If fasting insulin, glucose, and HbA1c have never been measured in the context of fertility, the metabolic picture has not been evaluated.

The oat milk dilemma and the possible impact on your fertility

Nutrient and Mitochondrial Support

Eggs are the most energy dependent cells in the body. Every stage of follicle maturation and early embryo division depends on the mitochondria the egg carries. A 2025 meta analysis of 16 studies and 2,773 women with DOR found that targeted supplementation for more than two months significantly improved high quality embryo rate and clinical pregnancy rates. CoQ10 in ubiquinol form had the strongest evidence.

The limiting factor is absorption. CoQ10 only reaches the follicle if the gut is functioning. Chronic inflammation depletes antioxidant reserves. Mineral deficiencies magnesium, zinc, selenium, iodine undermine the mitochondrial cofactor chain. Supplementation without a gut assessment and functional nutrient panel is an incomplete picture.

Oral nutritional supplements and DOR: 16 studies, 2,773 participants. PMC. 2025.

Gut and Absorption

The gut determines whether nutrients reach the follicle, how estrogen is metabolized, and whether chronic low grade inflammation is being driven into ovarian tissue. It is upstream of almost everything else in the DOR picture.

Gut dysbiosis can be present without digestive symptoms. It shows up in the labs deficiencies that do not respond, hormones that do not clear, inflammation that does not resolve.

If nutrients are not holding despite consistent supplementation, or thyroid conversion is not improving despite medication, gut function is part of the picture that has not been evaluated.

Why addressing digestive symptoms can improve reproductive health

Environmental Exposure

BPA, phthalates, pesticide residues, and heavy metals have been documented as directly suppressing AMH. They accumulate, interfere with hormone receptor function, and impair thyroid conversion. Hair Tissue Mineral Analysis gives heavy metal burden and mineral status together what has been accumulating and what has been depleted.

This is almost never ordered as part of a fertility workup. When it is evaluated, it is consistently one of the more revealing pieces of the DOR picture.

Zhang Y et al. Environmental toxin exposure and diminished ovarian reserve markers. Int J Environ Res Public Health. 2022.

Fertility-friendly non-toxic lubricants

Structural Evaluation and Male Factor

Before any transfer can succeed, the uterine environment needs to be assessed polyps, fibroids, scar tissue, blocked tubes, cysts. The functional question goes further: why are fibroids or cysts growing. In many women with DOR we see estrogen not being cleared or metabolized properly relative to progesterone. The DUTCH test shows the metabolic pathway estrogen is going down and whether the hormonal environment is supporting implantation.

With fewer eggs per cycle, what the sperm brings to the embryo matters more. Standard semen analysis does not assess DNA integrity. A 2025 study of 870 ICSI cycles found each 1% increase in sperm DNA fragmentation reduced top quality blastocyst odds by 2.5%. This is almost never evaluated where a partner is involved.

Sperm DNA Fragmentation Impairs Early Embryo Development: 870 ICSI Cycles. Int J Mol Sci. 2025.

DUTCH test and what it tells us about your hormones

A Pattern We Recognized

This is what it looks like when the full picture is actually evaluated.

She came in with one ovary, endometriosis, DOR, low AMH, and high FSH. This was secondary infertility. She had conceived before. Then came pregnancy, birth, and postpartum nutritional reserves depleted, stress accumulated, the body never fully recovered. A cyst was growing on her remaining ovary. She was preparing for another retrieval cycle.

When we looked at the full picture, what we found was not in the protocol. Digestive issues normalized for years. Adrenal imbalances never evaluated as a fertility factor. Nutrients not absorbing. Nervous system dysregulation running beneath the surface. None of it had been connected to her ovarian reserve. 

When those things were addressed, her body responded.

She went ahead with IVF, moved forward with the retrieval as planned. When they went in, they found she was already pregnant. She had conceived naturally. The pregnancy was already there.

Read the full story

Is DOR Reversible?

The honest answer depends on what is driving the picture.

Age related reserve decline is real and it is not fully reversible. But what we consistently see is that the DOR classification is applied before the reversible contributors have been investigated. Thyroid autoimmunity, chronic inflammation, gut dysfunction, metabolic instability, adrenal depletion, nutritional depletion these can all suppress ovarian function in ways that shift when they are addressed.

We see AMH rise. We see FSH come down. We see cycles return. We see egg quality improve in the retrievals that follow a genuine preparation window. None of that is guaranteed. But all of it becomes possible when the evaluation goes far enough to find what was actually driving the picture.

Can you reverse premature ovarian insufficiency naturally

Can Diminished Ovarian Reserve Be Improved?

The question we hear most often is whether anything can change. The answer is nuanced and more hopeful than most women are told.

Reserve markers are not fixed. AMH fluctuates. Antral follicle count changes. FSH can come down. What determines whether these markers shift is whether the biological environment driving the picture has been addressed not whether the number is low.

• When inflammation is reduced, follicle recruitment often improves
• When thyroid autoimmunity is addressed, ovarian responsiveness can shift
• When gut function is restored, nutrients reach the follicle and egg quality changes
• When adrenal patterns are supported, the hormonal cascade that drives follicle development stabilizes

Not every case changes. Not every number moves. But the cases where nothing improves are almost always cases where the biological picture was never fully evaluated in the first place.

Oral nutritional supplements and DOR: 16 studies, 2,773 participants. PMC. 2025.

The Conventional Approach and What It Centers On

When a DOR diagnosis arrives, the clinic conversation centers on one question: how do we get more eggs. High dose stimulation. DHEA. Back to back retrievals. Mini IVF. At some point, donor eggs. The urgency is real. But urgency is not the same as completeness.

What the Research Shows on Stimulation Dose

Higher stimulation doses increased eggs retrieved in women with DOR across 38 randomized controlled trials. That increase did not translate into improved clinical pregnancy rates. Egg quality shaped in the months before retrieval is the determining variable. Dose does not change what the egg developed inside.

Conforti A et al. Fertil Steril. 2024.

DHEA The Standard Recommendation Nobody Measures First

DHEA has real evidence in DOR. The question before starting is whether DHEAS has been measured and why it is low. If the answer is adrenal depletion, addressing the adrenals changes the picture more fundamentally than adding DHEA on top of a depleted system. Supplementing without that context can drive androgen excess.

Zhang J et al. Efficacy of DHEA priming in women with poor ovarian response. Front Endocrinol. 2023.

I have DOR and have been recommended DHEA -- should I take it

Ovarian PRP Rejuvenation

PRP uses growth factors from your own blood, injected directly into ovarian tissue. Outcomes vary by case and technique. What is almost never part of the PRP conversation: the biological environment has to be prepared to receive it. If that tissue is chronically inflamed or nutrient depleted, the response will be limited.

Have you done this before ovarian PRP rejuvenation

Can You Get Pregnant With Diminished Ovarian Reserve?

Yes. A 2023 Fertility and Sterility study followed women aged 30 to 44 trying to conceive naturally. Women with diminished ovarian reserve were just as likely to have a baby as women with normal reserve once age and other factors were accounted for. DOR as a standalone marker does not determine pregnancy potential. The biological environment does.

What we see in this population: egg quality improves. Retrievals that previously produced few or poor quality eggs produce different results after a genuine preparation window. Natural conception occurs in cases where it had not for years. None of that is every case. But it is what becomes possible when the evaluation goes far enough.

Harris BS et al. Markers of ovarian reserve as predictors of future fertility. Fertil Steril. 2023.

Pregnant with DOR: how she improved egg quality with low AMH and high FSH

What We See in Case Reviews

The information is almost always already there. In previous labs, in the symptom history, in the pattern across cycles. It is not being read as a connected picture.

• Thyroid antibodies elevated in previous labs  flagged nowhere, connected to nothing. TSH normal so the thyroid was cleared.
• Hashimoto's on the history form managed on medication, assumed handled. Antibodies never rechecked in the context of fertility.
• Homocysteine never tested. Taking folic acid with an MTHFR variant. The methylation pathway undersupported the entire time.
• hsCRP between 1 and 3 mg/L unremarkable to the clinic, never connected to the recurrent losses or the reserve decline.
• Ferritin well below 80 ng/mL flagged normal by the lab. Oxygen delivery to the follicle compromised through multiple cycles.
• Gut dysbiosis present with no digestive symptoms. Nothing responding despite months of supplementation. Nutrients not reaching target tissues.
• Progesterone never measured seven days post ovulation. Chemical pregnancies attributed to egg quality or bad luck.
• Cortisol curve flat when it should be peaked. DHEA low. Nobody asked why.
• ANA positive, sitting in the labs, never connected to the implantation failures or the early losses.
• Sperm DNA fragmentation never tested where a partner was involved. Semen analysis appeared normal so male factor was ruled out. 

The pattern is not a lack of effort. It is a lack of interpretation. The data is often already there. It just has not been connected.

On Donor Eggs and Preparation

Donor eggs are a valid and meaningful path. We have helped many women conceive with donor eggs. But donor cycles fail when the biological environment was never addressed.

Donor eggs change the egg. They do not change the uterine environment, the immune picture, the inflammatory burden, or the vaginal microbiome.

If the environment was not prepared, the outcome can be the same regardless of where the egg came from. Working on your health before any next step is not optional whether the path forward uses your own eggs or someone else's.

Questions We Hear Most About DOR

I was just diagnosed with DOR. What should I do first?

Get curious about what is driving it before accepting it as a fixed ceiling. That means looking at the systems behind the numbers thyroid antibodies, inflammatory markers including hsCRP and homocysteine, nutrient status, gut function, adrenal and cortisol patterns. Most of those have never been evaluated as part of the DOR picture.

Is DOR the same as early menopause?

No. DOR describes reduced ovarian reserve while cycles are still present and ovarian function is still occurring. Early menopause involves cessation of ovarian function with a distinct hormonal picture elevated FSH, low estrogen, absent or highly irregular cycles. Having DOR today does not mean early menopause is inevitable.

I have DOR and have had miscarriages. Are they connected?

Often yes. The inflammatory and autoimmune contributors that drive reserve decline frequently create an environment that cannot sustain a pregnancy. Thyroid antibodies, elevated ANA, elevated homocysteine, low progesterone measured at the wrong time these are not separate problems. They are the same picture showing up in different ways. The miscarriage evaluation and the DOR evaluation need to happen together.

My doctor recommended DHEA. Should I take it?

The evidence for DHEA in DOR is real. But the question before starting is whether DHEAS has been measured and why it is low. If the answer is adrenal depletion from sustained stress, addressing the adrenals changes the picture more fundamentally than supplementing on top of a depleted system. Supplementing without that baseline can drive androgen excess.

I am considering donor eggs. Do I still need to work on my health?

Yes. Donor eggs change the egg. They do not change the uterine environment, the immune picture, the inflammatory burden, or the vaginal microbiome. Donor cycles fail when the biological environment is not prepared. The preparation work matters regardless of which path you take.

What is the difference between DOR and poor ovarian response?

DOR refers to reduced reserve markers AMH below 1.0 ng/mL, antral follicle count below expected range, FSH above 10 mIU/mL. Poor ovarian response describes how the ovaries responded during a stimulated IVF cycle. The POSEIDON criteria classifies by both. Neither one answers what is driving the picture underneath.

More From the Fab Fertile Community

Success story: one ovary, DOR, endometriosis, low AMH and high FSH 

Pregnant with DOR: how she improved egg quality with low AMH and high FSH 

How to improve egg quality naturally and support DOR 

Pregnant naturally at 43 with low AMH and high FSH  

Sources and Research

1. Harris BS et al. Markers of ovarian reserve as predictors of future fertility. Fertil Steril. 2023.

2. Conforti A et al. Therapeutic management in women with DOR: RCT meta-analysis. Fertil Steril. 2024. 

3. Zhang J et al. Efficacy of DHEA priming in women with poor ovarian response. Front Endocrinol. 2023. 

4. Oral nutritional supplements and DOR: 16 studies, 2,773 participants. PMC. 2025. 

5. Ticconi C et al. Antinuclear antibodies positivity in women of reproductive age. J Reprod Immunol. 2023.

6. Wang H et al. Homocysteine level related to age is associated with embryo quality in DOR. Front Reprod Health. 2022. 

7. DOR associated with metabolic disturbances and hyperhomocysteinemia. J Obstet Gynaecol. 2023.

8. Hashimoto's Thyroiditis and Female Fertility. PMC. 2025. 

9. Sperm DNA Fragmentation Impairs Early Embryo Development: 870 ICSI Cycles. Int J Mol Sci. 2025. 

10.   Zhang Y et al. Environmental toxin exposure and diminished ovarian reserve markers. Int J Environ Res Public Health. 2022.

11.   Hu Y et al. Impact of psychological stress on ovarian function. Int J Mol Med. 2025. 

12.   Minguez-Alarcon L et al. Perceived stress and markers of ovarian reserve among subfertile women. Reprod Biomed Online. 2023. 

13.   Chronic unpredictable stress induces diminished ovarian reserve. Scientific Reports. 2024. 

14.   ASRM. Subclinical hypothyroidism in the infertile female population: a guideline. 2024.